Nano-encapsulation and characterization of baricitinib using poly-lactic-glycolic acid co-polymer

Baricitinib is a recently approved anti-rheumatic drug having very poor aqueous solubility and hence its performance suffers from low or inconsistent oral bioavailability. The purpose of the study was to develop and evaluate poly lactic-co-glycolic acid (PLGA) nanoparticles of baricitinib in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Mohammad Javed, Alshahrani, Saad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488806/
https://www.ncbi.nlm.nih.gov/pubmed/31061617
http://dx.doi.org/10.1016/j.jsps.2019.01.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488806/
https://www.ncbi.nlm.nih.gov/pubmed/31061617
http://dx.doi.org/10.1016/j.jsps.2019.01.012

Ejemplares similares